Pfizer acquired Metsera in 2025, which consolidated DD-03 and DD-15 into Pfizer's internal pipeline
But of course, with volatility, you should always wonder if the market is right or just reacts like a fish to bait
Volume progression in polycystic kidney disease
Makunts T, Alpatty S, Lee KC, Atayee RS, Abagyan R (2019) Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
This may indicate the need for dose adjustment, evaluation of concurrent medications that might affect weight (such as certain antidepressants or corticosteroids), or assessment of underlying conditions like hypothyroidism or polycystic ovary syndrome that could impair weight loss